Home » Topics » Regulatory » Patents

Patents
RSS

New antiplatelet agents prepared by Sankyo/Ube researchers

May 29, 1998

Neurokinin antagonists for bronchoconstriction, neurogenic inflammation

May 29, 1998

Bristol-Myers Squibb presents derivatives of indolopyrrolocarbazoles as antitumor agents

May 29, 1998

P2T purinoceptor receptor antagonists with platelet antiaggregatory activity

May 28, 1998

New HIV protease inhibitors disclosed by Merck & Co.

May 28, 1998

Antimicrobial peptide isolated from Korean frog

May 28, 1998

RCT describes truncated chemokine analogues for rheumatoid arthritis

May 28, 1998

Bombesin receptor antagonists developed by Warner-Lambert

May 28, 1998

Dong Wha discloses novel antitumor agents with few side effects

May 27, 1998

Oxis presents new antiinflammatory agents with multiple mechanisms of action

May 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...